Alyeska Investment Group’s CAMP4 Therapeutics Corporation Common Stock CAMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$290K Hold
200,000
﹤0.01% 532
2025
Q1
$800K Hold
200,000
﹤0.01% 446
2024
Q4
$1.04M Buy
+200,000
New +$1.04M ﹤0.01% 492